Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ISATUXIMAB for Primary amyloidosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 31 adverse event reports in the FDA FAERS database where ISATUXIMAB was used for Primary amyloidosis.

Most Reported Side Effects for ISATUXIMAB

Side Effect Reports % Deaths Hosp.
Neutropenia 396 10.0% 31 146
Pneumonia 304 7.7% 53 249
Covid-19 248 6.2% 17 139
Plasma cell myeloma 241 6.1% 77 73
Thrombocytopenia 227 5.7% 16 100
Infusion related reaction 213 5.4% 15 117
Pyrexia 202 5.1% 18 163
Anaemia 197 5.0% 23 118
Diarrhoea 162 4.1% 11 103
Off label use 126 3.2% 22 28
Febrile neutropenia 125 3.2% 7 112
Acute kidney injury 118 3.0% 29 96
Dyspnoea 117 3.0% 14 65
Infection 116 2.9% 20 93
Nausea 112 2.8% 20 60

Other Indications for ISATUXIMAB

Plasma cell myeloma (2,762) Plasma cell myeloma refractory (778) Product used for unknown indication (174) Minimal residual disease (40) Plasma cell myeloma recurrent (18) Acute myeloid leukaemia (12) B-cell type acute leukaemia (10) Lymphoma (10) Stem cell transplant (10) Plasma cell leukaemia (6)

Other Drugs Used for Primary amyloidosis

BORTEZOMIB (905) DEXAMETHASONE (744) DARATUMUMAB (609) CYCLOPHOSPHAMIDE (580) LENALIDOMIDE (233) MELPHALAN (163) POMALIDOMIDE (126) VENETOCLAX (47) DARATUMUMAB\HYALURONIDASE-FIHJ (44) IXAZOMIB (40)

Related Pages

ISATUXIMAB Full Profile All Primary amyloidosis Drugs ISATUXIMAB Demographics ISATUXIMAB Timeline